ATHA
Price
$0.39
Change
-$0.01 (-2.50%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
15.6M
69 days until earnings call
MNKD
Price
$4.49
Change
-$0.03 (-0.66%)
Updated
Aug 28 closing price
Capitalization
1.38B
74 days until earnings call
Interact to see
Advertisement

ATHA vs MNKD

Header iconATHA vs MNKD Comparison
Open Charts ATHA vs MNKDBanner chart's image
Athira Pharma
Price$0.39
Change-$0.01 (-2.50%)
Volume$400
Capitalization15.6M
MannKind
Price$4.49
Change-$0.03 (-0.66%)
Volume$6.03M
Capitalization1.38B
ATHA vs MNKD Comparison Chart in %
Loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHA vs. MNKD commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Buy and MNKD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ATHA: $0.40 vs. MNKD: $4.49)
Brand notoriety: ATHA and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 56% vs. MNKD: 179%
Market capitalization -- ATHA: $15.6M vs. MNKD: $1.38B
ATHA [@Biotechnology] is valued at $15.6M. MNKD’s [@Biotechnology] market capitalization is $1.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileMNKD’s FA Score has 0 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • MNKD’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than ATHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 2 TA indicator(s) are bullish while MNKD’s TA Score has 6 bullish TA indicator(s).

  • ATHA’s TA Score: 2 bullish, 5 bearish.
  • MNKD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MNKD is a better buy in the short-term than ATHA.

Price Growth

ATHA (@Biotechnology) experienced а +0.28% price change this week, while MNKD (@Biotechnology) price change was +13.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

ATHA is expected to report earnings on Nov 06, 2025.

MNKD is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.38B) has a higher market cap than ATHA($15.6M). MNKD YTD gains are higher at: -30.171 vs. ATHA (-32.589). MNKD has higher annual earnings (EBITDA): 79.1M vs. ATHA (-56.92M). MNKD has more cash in the bank: 179M vs. ATHA (29.8M). ATHA has less debt than MNKD: ATHA (1.02M) vs MNKD (46.8M). MNKD has higher revenues than ATHA: MNKD (302M) vs ATHA (0).
ATHAMNKDATHA / MNKD
Capitalization15.6M1.38B1%
EBITDA-56.92M79.1M-72%
Gain YTD-32.589-30.171108%
P/E RatioN/A40.82-
Revenue0302M-
Total Cash29.8M179M17%
Total Debt1.02M46.8M2%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHAMNKD
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 22 days ago
80%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UGP3.700.26
+7.56%
Ultrapar Participacoes SA
SGMO0.54N/A
+0.54%
Sangamo Therapeutics
FDUS21.440.06
+0.28%
Fidus Investment Corp
ADM62.66-0.05
-0.08%
Archer Daniels Midland Company
TKLF3.53-0.03
-0.84%
Tokyo Lifestyle Co Ltd

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with CSCI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then CSCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
-1.13%
CSCI - ATHA
42%
Loosely correlated
+1.00%
ALNY - ATHA
35%
Loosely correlated
-0.41%
OGEN - ATHA
35%
Loosely correlated
+1.67%
PCVX - ATHA
33%
Poorly correlated
+0.72%
MNKD - ATHA
32%
Poorly correlated
-0.66%
More

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with VCYT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-0.66%
VCYT - MNKD
44%
Loosely correlated
+4.68%
DAWN - MNKD
42%
Loosely correlated
N/A
LXRX - MNKD
42%
Loosely correlated
+1.77%
INSM - MNKD
40%
Loosely correlated
+0.33%
NRIX - MNKD
37%
Loosely correlated
-1.47%
More